Published in J Clin Microbiol on December 01, 2002
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Current and developing technologies for monitoring agents of bioterrorism and biowarfare. Clin Microbiol Rev (2005) 2.53
Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis. Clin Diagn Lab Immunol (2005) 0.91
Long-term frozen storage of urine samples: a trouble to get PCR results in Schistosoma spp. DNA detection? PLoS One (2013) 0.83
Nucleic Acid Amplification Based Diagnostic of Lyme (Neuro-)borreliosis - Lost in the Jungle of Methods, Targets, and Assays? Open Neurol J (2012) 0.81
Inability of one-step real-time PCR to detect Borrelia burgdorferi DNA in urine. J Clin Microbiol (2004) 0.76
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med (1994) 4.07
Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever. J Clin Microbiol (1992) 2.46
Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: results of a prospective study. Arthritis Rheum (2001) 2.20
Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis (2001) 1.94
Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med (1995) 1.74
Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immun (1991) 1.63
Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction. J Clin Microbiol (1992) 1.54
European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr (1996) 1.51
PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev (1997) 1.23
An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J Clin Microbiol (1997) 1.15
Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples. J Clin Microbiol (2001) 1.15
Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy. J Clin Microbiol (1996) 1.14
Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol (1998) 1.05
Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J Clin Microbiol (1994) 0.98
Effects of various handling and storage conditions on stability of Treponema pallidum DNA in cerebrospinal fluid. J Clin Microbiol (1998) 0.96
Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn (2000) 0.95
Amplification of DNA of Borrelia burgdorferi in urine samples of patients with granuloma annulare and lichen sclerosus et atrophicus. Arch Dermatol (1999) 0.88
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis. Diagn Microbiol Infect Dis (1995) 0.88
Different methods of sample preparation influence sensitivity of Mycobacterium tuberculosis and Borrelia burgdorferi PCR. PCR Methods Appl (1994) 0.86
Prevalence of antibodies to Borrelia burgdorferi flagellin in Styrian blood donors. Zentralbl Bakteriol (1993) 0.83
Solid-hase hemadsorption: a method for rapid detection of Treponema pallidum-specific IgM. Sex Transm Dis (1980) 1.85
European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr (1996) 1.51
Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J Infect Dis (2000) 1.45
Abnormal epidermal changes after argon laser treatment. J Am Acad Dermatol (1991) 1.40
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
Specificity of the Treponema pallidum haemagglutination test. Analysis of results. Br J Vener Dis (1981) 1.23
Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob Agents Chemother (1995) 1.10
Serine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway. Pain (2010) 1.07
Diagnosis of neurosyphilis by examination of the cerebrospinal fluid. Br J Vener Dis (1981) 1.05
Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis. J Clin Microbiol (2001) 1.04
Biologic mechanisms of oral cancer pain and implications for clinical therapy. J Dent Res (2011) 1.01
Significance of laboratory findings for the diagnosis of neurosyphilis. Int J STD AIDS (2000) 0.97
European Lyme borreliosis. Ann N Y Acad Sci (1988) 0.96
CXCL13 chemokine in pediatric and adult neuroborreliosis. Acta Neurol Scand (2011) 0.93
Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus. Br J Dermatol (2001) 0.93
Is localised scleroderma a Borrelia infection? Lancet (1985) 0.92
DNA dot-blot hybridization implicates human papillomavirus type 11-DNA in epithelioma cuniculatum. J Med Virol (1989) 0.91
Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene. Oncogene (2008) 0.90
Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma. Br J Dermatol (1996) 0.90
Evidence for spirochetal origin of circumscribed scleroderma (morphea). Acta Derm Venereol (1987) 0.88
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis. Diagn Microbiol Infect Dis (1995) 0.88
Amplification of DNA of Borrelia burgdorferi in urine samples of patients with granuloma annulare and lichen sclerosus et atrophicus. Arch Dermatol (1999) 0.88
Treatment of eosinophilic annular erythema with chloroquine. Acta Derm Venereol (2000) 0.88
Metastatic epithelioid angiosarcoma to the mandible: report of a case and review of the literature. Int J Oral Maxillofac Surg (2013) 0.88
The presence of the antilingula and its relationship to the true lingula. Br J Oral Maxillofac Surg (1995) 0.85
Isolation of Borrelia afzelii from circumscribed scleroderma. Br J Dermatol (1999) 0.84
Incidence of chancroid in Vienna from 1980 to 1988. Int J Dermatol (1989) 0.83
Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome. Dermatology (2013) 0.83
Evidence for spirochetal origin of Sudeck's atrophy (algodystrophy, reflex sympathetic dystrophy). Arch Orthop Trauma Surg (1989) 0.83
Treatment failure with rituximab in a patient with pemphigus vulgaris. J Eur Acad Dermatol Venereol (2008) 0.82
Pinta in Austria (or Cuba?): import of an extinct disease? Arch Dermatol (1999) 0.82
Downregulation of class II molecules on epidermal Langerhans cells in Lyme borreliosis. Br J Dermatol (2000) 0.81
Laboratory evidence for impaired cellular immunity in different stages of syphilis. J Invest Dermatol (1982) 0.81
Adverse skin reactions to infliximab in the treatment of intraocular inflammation. Eye (Lond) (2006) 0.80
Lingual nerve damage due to inferior alveolar nerve blocks: a possible explanation. J Am Dent Assoc (2003) 0.80
Progressive circumscribed sclerosis--a novel side-effect of immunotherapy with aluminium-adsorbed allergen extracts. Allergy (2009) 0.79
Diagnosis of Chlamydia trachomatis infection--culture versus serology. Eur J Epidemiol (1988) 0.79
Acute exacerbation of systemic scleroderma in Borrelia burgdorferi infection. J Eur Acad Dermatol Venereol (2005) 0.79
Keratitis, ichthyosis, and deafness syndrome with glycogen storage. Arch Dermatol (1985) 0.78
Cerebrospinal fluid immunoglobulins in neurosyphilis. Br J Vener Dis (1981) 0.78
[Serological diagnosis of syphilis by the SPHA test (author's transl)]. Wien Klin Wochenschr (1981) 0.78
[Iloprost therapy in systemic sclerosis]. Hautarzt (2003) 0.78
[HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests]. Wien Klin Wochenschr (1987) 0.77
[Recent progress in syphilis serology]. Wien Klin Wochenschr (1983) 0.77
Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis. Infection (1996) 0.77
Aging and diabetes increase the aggregating potency of rat skin collagen towards normal platelets. Thromb Haemost (1988) 0.76
Acrodermatitis chronica atrophicans in association with lichen sclerosus et atrophicans: tubulo-interstitial nephritis and urinary excretion of spirochete-like organisms. Acta Derm Venereol (1987) 0.76
CXCL13 and B-cell activating factor as putative biomarkers in systemic sclerosis. Br J Dermatol (2013) 0.76
Species identification of Borrelia burgdorferi sensu lato from tick and human isolates in Styria (Austria) by PCR-RFLP analysis. Wien Klin Wochenschr (1999) 0.76
Inability of one-step real-time PCR to detect Borrelia burgdorferi DNA in urine. J Clin Microbiol (2004) 0.76
Congenital anetoderma induced by intrauterine infection? Arch Dermatol (1997) 0.75
Discontinuing long-term Iloprost treatment for Raynaud's Phenomenon and systemic sclerosis: a single-center, randomized, placebo-controlled, double-blind study. Acta Dermatovenerol Alp Pannonica Adriat (2011) 0.75
Morphea another manifestation of Lyme disease? Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.75
Erythematous macules in a 14-year-old girl. Clin Exp Dermatol (2010) 0.75
[Specificity and sensitivity of the solid phase hemadsorption test: a study of treated and untreated syphilitics]. Z Hautkr (1983) 0.75
Treatment of livedoid vasculopathy with alprostadil (PGE-1): case report and review of published literature. J Eur Acad Dermatol Venereol (2012) 0.75
[Molecular biology of human T-lymphotropic retroviruses (HTLV)]. Wien Med Wochenschr (1986) 0.75
[Eccrine hidradenitis. Case report and review of the literature]. Hautarzt (1997) 0.75
[The SPHA technic (solid phase hemadsorption) in syphilis serology. A year's experience in routine laboratory procedure]. Hautarzt (1982) 0.75
[The enzyme-linked immunosorbent assay technic in syphilis serology (report on experiences)]. Wien Klin Wochenschr (1984) 0.75
[Diagnosis of Chlamydia infections]. Wien Klin Wochenschr (1987) 0.75
[Cryotherapy in discoid lupus erythematosus (DLE)]. Ophthalmologe (2008) 0.75
[Femorogluteal manifestation of lymphogranuloma venereum]. Hautarzt (1989) 0.75
[Antibody titer against B-streptococci in human gamma globulin]. MMW Munch Med Wochenschr (1981) 0.75
[Psoriasis as Koebner phenomenon in erythma migrans]. Hautarzt (2002) 0.75
[AIDS diagnosis: virus detection, antibody detection, diagnostic and prognostic significance of the findings]. Wien Med Wochenschr (1988) 0.75
[Treatment of a tibial fracture in recessive epidermolysis bullosa herditaria dystrophica]. Unfallheilkunde (1984) 0.75
[Serology of HIV infection]. Hautarzt (1989) 0.75
Parenteral interferon-alpha treatment of psoriasis. Dermatologica (1987) 0.75
Gauze padding: a simple technique to delineate small oral cavity tumors. AJNR Am J Neuroradiol (2011) 0.75
Anatomic evaluation of anterior platysma muscle. Int J Oral Maxillofac Surg (1994) 0.75
[The use of high-pressure liquid chromatography in syphilis serodiagnosis]. Wien Med Wochenschr (1982) 0.75
Crossed immunoelectrophoresis of native cerebrospinal fluid on cellulose acetate membranes. Clin Chim Acta (1980) 0.75
Treatment and course of erythema chronicum migrans. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.75
[Severe initial manifestations of psoriasis in staphylococcal infections]. Wien Klin Wochenschr (2001) 0.75
[Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas]. Hautarzt (1987) 0.75